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Abstract 9 
Scorpion venoms provide a rich source of anti-microbial peptides.  Here we characterise three 10 
from the venom of Scorpion maurus palmatus.  Smp13 is biologically inactive, despite 11 
sharing homology with other antimicrobial peptides, probably because it lacks a typically 12 
charged structure. Both Smp-24 and Smp-43 have broad spectrum antimicrobial activity, 13 
disrupting bacterial membranes.  In addition, there is evidence that Smp24 may inhibit DNA 14 
synthesis in Bacillus subtilis.  Smp24 haemolysed red blood cells but in contrast, Smp43 was 15 
non-haemolytic.  The introduction of a flexible Gly-Val-Gly hinge into the middle of Smp24 16 
did not alter the haemolytic activity of Smp24 (as might have been predicted from earlier 17 
studies with Pandinin2 (Pin2), although C-terminal truncation of Smp-24 reduced its 18 
haemolytic activity, in agreement with earlier Pin 2 studies.  Smp24 and its derivatives, as 19 
well as Smp-43, were all cytotoxic (ATP release assay) toward mammalian HepG2 liver 20 
cells.  Our results highlight the beneficial effect of helical-hinge-helical conformation on 21 
promoting prokaryotic selectivity of long chain scorpion AMPs, as well as the importance of 22 
examining a wide range of mammalian cell types in cytotoxicity testing. 23 
24 
2 
 
Introduction 25 
Over the last few decades an increasing number of pathogenic microorganisms have 26 
developed resistance to conventional antibiotics posing problems in the management of 27 
infection.  Although treatment options for some Gram positive pathogens have undoubtedly 28 
improved, our ability to successfully combat many Gram negative bacteria is becoming a 29 
serious issue (Livermore., 2009). The problems in modern antibiotic drug development of 30 
being able to design agents that are not easily susceptible to resistance (Jenssen et al., 2006) 31 
has meant that there has been a dramatic decline in the development of new antibiotics during 32 
the same period.  33 
Antimicrobial peptides (AMPs) represent an ancient host defence mechanism of the innate 34 
immune system that transverses the evolutionary spectrum and to this day remains an 35 
effective strategy against invading pathogens in the animal kingdom.  AMPs are found in all 36 
multicellular organisms, from molluscs to humans.  They are present in vertebrate neutrophils 37 
and leukocytes, invertebrate haemolymph, amphibian skin secretions and nearly all types of 38 
plant cells (Bahar and Ren., 2013).   The predominant mechanism of action of AMPs is to 39 
disrupt the structure and function of microbial cell membranes.  Because of their selectivity 40 
for prokaryotes and their membrane-disruptive mechanisms for which microbes have little 41 
natural resistance, the spotlight in recent years has turned towards the development of novel 42 
antibiotics from these peptides (Zasloff., 2002, Hancock and Sahl., 2006) 43 
AMP's are positively charged peptides of variable length (typically 12-70 amino acids) which 44 
can be broadly divided into four structural classes:  (i) amphipathic linear α-helix, (ii) 45 
amphipathic β-sheet constrained and stabilised by disulphide bridges, (iii) extended linear 46 
peptides, lacking secondary structure and enriched with one or more amino acids (e.g. 47 
histidine, glycine, proline/ arginine) and (iv) loop peptides, which adopt a helical type-II 48 
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circular structure because of a high abundance of proline residues (Powers., 2003).  Yeaman 49 
and Yount (2003) have reviewed various structural parameters- amphipathicity, charge, 50 
hydrophobicity, polar angle and conformation -which the authors suggest are crucial 51 
molecular determinants for identifying a peptide that has selective toxicity for prokaryotic 52 
membranes. 53 
The key factor to membrane disruption is the initial electrostatic attraction of the peptide to 54 
the negatively charged bacterial membrane surface (Huang., 2000, Shin et al., 2001, Glukhov 55 
et al., 2005). After initial electrostatic attraction, a threshold concentration is often required 56 
before membrane disruption can occur (Huang., 2000, Melo et al., 2009).  Following this 57 
initial step, a number of mechanisms have been proposed to account for membrane 58 
disruption: (i) Barrel stave mechanism - peptide oligomerization creates a central pore lumen 59 
characterised by peptide-peptide interactions (Baumann and Mueller., 1974).  (ii)  Toroidal 60 
mechanism - the pore lumen is lined by interactions between peptide and phospholipid head 61 
groups (Matsuzaki et al., 1996; Ludtke et al., 1996).  (iii) Carpet model peptides cover 62 
("carpet") the membrane surface and at a critical concentration, transient pores are formed 63 
which allow the peptide access to the inner leaflet (Shai et al., 1999 & Yamaguchi et al., 64 
2001). In this last model, it is proposed that peptides can span the transmembrane bilayer on 65 
each membrane surface, causing curvature of the membrane to protect the acyl chains, which 66 
then leads to the disintegration of the bilayer, due to micelle formation (Teixeria et al., 2012).  67 
AMPs have been found in the venoms of all venomous species examined. The physical 68 
process of envenomation can variously lead to damage of fangs or telsons, resulting in 69 
microbial infection. It is therefore logical to suggest that there has been evolutionary pressure 70 
on venoms to produce AMPs as a protective measure to sterilize any infection (de Lima et al., 71 
2009). The AMP content of venoms varies widely between with a significant intra-species 72 
variation, dependent on such factors as age, sex, geography and climate (Calvete., 2013). 73 
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Scorpion venoms provide an especially rich and diverse source of AMPs, with over 40 74 
peptides having been characterised to date (see Harrison et al., 2014 for a recent review); the 75 
applications of proteomic and genomic based approaches are identifying new peptides at an 76 
ever increasing rate.  In one such study Abdel-Rahman et al., (2013) examined the venom of 77 
the North African scorpion Scorpio maurus palmatus; the study identified four potentially 78 
novel AMPs, namely a 76-residue cysteine-containing peptide (Smp76), and three alpha-79 
helical peptides (Smp13, Smp24 and Smp43). Smp24 shares homology with Pandinin 2 (Pin 80 
2) (54 %) an AMP from Pandinus imperator.  Using Pin2 as a model AMP, Possani and 81 
colleagues (Rodriguez et al., 2011) have demonstrated the importance of a structural proline 82 
"kink" in the middle of an otherwise un-interrupted alpha-helix that confers potent non-83 
specific pore-forming activity toward both eukaryotic and prokaryotic membranes; 84 
substitution of this Pro residue for a more hydrophobic Gly-Val-Gly "hinge",  dramatically 85 
reduces the haemolytic activity of Pin2 and makes the modified peptide more selective for 86 
prokaryotic membranes.   The present study describes the biological characterisation of Smp 87 
13, Smp24 and Smp43 and in particular examines the effects of disrupting the central Pro 88 
residue of Smp24 with respect to its antimicrobial selectivity, as distinct from non-specific 89 
cytotoxic properties.  90 
Materials and Methods 91 
Materials 92 
All peptides were synthesised using FMOC solid-phase chemistry and were purchased from 93 
Think Peptides (Oxford, UK) (Purity analysis see Supplementary data). All peptide 94 
sequences are listed in Table 1.  All other solvents, chemicals and tissue culture reagents 95 
were of the highest grade available and were obtained from Sigma (Gillingham, UK).   96 
 97 
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Bacterial strains 98 
Microbes used throughout this study were as follows: Escherichia coli JM109, Pseudomonas 99 
aeruginosa NCIMB 8295, Bacilus subtilis NCIMB 8024, Staphylococcus aureus SH1000, 100 
Klebsiella pneumoniae NCTC 13439, Staphylococcus epidermidis ATCC12228 & Candida 101 
albicans ATCC10231. Antibiotic resistant strains of S. aureus used were as follows: 102 
methicillin-resistant S. aureus (MRSA) ATCC 33591, epidemic methicillin-resistant S. 103 
aureus (EMRSA) 15 and EMRSA-16, clinical isolate MRSA mecA mupA positive, along 104 
with the vancomycin intermediate resistant S. aureus (VISA) Mu50, and a clinical VISA 105 
isolate KM126. All bacteria were from a culture collection held at Sheffield Hallam 106 
University. 107 
Antimicrobial assay 108 
All antimicrobial assays were carried out by the microplate dilution method (Andrews., 2001) 109 
using an automated plate reader (CENios Plus, Tecan, Switzerland). Synthetic AMPs were 110 
examined at a concentration range of 0-512 μg/ml with Muller-Hinton growth medium. 111 
Haemolysis assay 112 
Haemolytic activity was determined on sheep erythrocytes as described (Corzo et al., 2001). 113 
Whilst differences in lipid composition are observed between sheep and human erythrocytes 114 
they share significant similarities in terms of cholesterol content and neutrally charged lipid 115 
composition (Nelson 1967) and therefore provide a reliable first screen for toxicity.  116 
Synthetic AMPs were examined at a concentration range of 0-512μg/ml using a plate reader 117 
(570nm, Infinite M200, Tecan, Switzerland) Triton X-100 (10%) was used as a positive 118 
control and deionised water as the negative control. All samples were tested in triplicate. 119 
ATP release assay 120 
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An ATP release assay (Sigma, UK) was used to determine the cytotoxic potential of peptides 121 
against HepG2 liver cells in accordance with the manufacturer's protocol. HepG2 cells were 122 
grown in DMEM (glutamate max medium) containing 1 g/l D-glucose, 10% foetal calf serum 123 
and 1% penicillin-streptomycin. Cells were grown (37˚C, 5% CO2 ) to 80% confluence. Cells 124 
were trypsinised, washed PBS and resuspended at the desired concentration to and seeded at 125 
a final density of 1.1 x 105 cells/well. Cells were incubated for 24 hrs, washed (PBS) and 126 
peptides (0.5-512 μg/ml) added (15 mins 37˚C). ATP release was quantitated using 127 
luciferin/luciferase in a bioluminescent assay. All assays were performed in triplicate. Triton 128 
X-100 (10%) was used as a positive control and deionised water as the negative control. 129 
Luminescence was determined on a Wallac Victor2 1420 multi-label counter (Perkin Elmer, 130 
Llantrisant, UK). 131 
Membrane integrity assay  132 
Bacterial membrane integrity following antimicrobial peptide attack was determined by the 133 
BacLight method (adapted from Hillard et al., 1999). Membrane integrity was determined for 134 
both Gram positive (S. aureus SH100) and Gram negative (E. coli JM109) organisms using 135 
the live/dead BacLight kit (Invitrogen UK). Overnight cultures were diluted with Muller-136 
Hinton broth to an optical density of between 0.5-0.6 at 600 nm.  For each sample to be 137 
tested, 500 μl of culture was pelleted (10,000 x g, 15 mins) and washed with PBS. The pellet 138 
was resuspended and each peptide was added at 4x MIC.  Peptides were incubated (10 mins, 139 
room temp) on a rocking platform. Each sample was then centrifuged (10,000 x g, 10 mins) 140 
and re-suspended in 500 μl of deionised water. The optical density was adjusted to 0.5 141 
OD600nm and then 1.2 μl of BacLight reagent was added according to the manufacturer's 142 
instructions and incubated (15 mins, room temp) in the dark.  The fluorescence excitation 143 
wavelength was set at 485nm and fluorescence emission measured at 645 nm and 530 nm to 144 
determine intact (green) and damaged (red) cells respectively. 100% loss of membrane 145 
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integrity was determined by the addition of Triton X-100 (10%) and deionised water was 146 
added as a negative control.  All assays were performed in triplicate. 147 
Intracellular bio-reporter gene assay 148 
To determine if any of the peptides had intracellular targets, a Bacillus subtilis reporter gene 149 
assay (Urban et al., 2007) was performed by analysing the effects of stress on specific 150 
intracellular bacterial targets, using a bioluminescent luciferase gene reporter Bacteria swere 151 
exposed to 1/2 x MIC of each peptide for 1, 1.5, 3 & 4 hours at 37˚C with luminescence 152 
determined using a Wallac Victor2 1420 multi-label counter (Perkin Elmer, Llantrisant, UK).  153 
All assays were performed in triplicate and responses were determined by calculating the % 154 
increase from the negative control (Phosphate buffered saline solution). 155 
CD spectra  156 
CD spectra were recorded on a JASCO J-700 spectropolarimeter at 22 ˚C using a 0.1 cm 157 
path-length cell. The spectral range was 190–250 nm and three scans were accumulated. 158 
Peptides (0.2 mg/ml) were dissolved in either water or 60% (v/v) aqueous 2,2,2-159 
trifluoroethanol (TFE).  160 
 161 
 162 
 163 
 164 
Results 165 
Using a microbroth dilution assay, no antimicrobial activity was detected (up to 512 g/ml) 166 
with Smp13.  In contrast, Smp24 and Smp43 displayed highest activity against Gram positive 167 
organisms (Table 2).  Removing the last four C-terminal residues of Smp24 (truncated 168 
Smp24, Smp24T) made a negligible difference to antimicrobial activity. Similarly, increasing 169 
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the conformational flexibility of Smp24 by inserting a "hinge" region in the middle of the 170 
peptide (replacing Pro-14 with Gly-Val-Gly, Smp24GVG) had limited effect.  Because of the 171 
strong activity observed with Smp24 towards S. aureus SH1000, this peptide was assayed 172 
against a wider range of S. aureus strains, including methicillin-resistant strains and strains 173 
with intermediate resistance towards vancomycin (Table 3). A wide range of MIC values 174 
were observed between strains, particularly between EMRSA-15 (MIC = 16 μg/ml) and 175 
EMRSA-16 (MIC = 512 μg/ml), highlighting the possibility of cross-resistance being 176 
acquired either through plasmid acquisition, mutation or phenotypic routes.   Both Smp24 177 
and Smp43 showed limited activity toward the yeast, C.albicans. 178 
The effects of the biologically active peptides upon bacterial membrane integrity determined 179 
that all peptides examined were membrane active with maximum disruption against both 180 
Gram-positive and Gram-negative species at a concentration of 4 x the MIC value observed 181 
(Table 4). 182 
Further evidence of membrane disruption was observed in B.subtilis, with all four active 183 
peptides inducing an almost x15-fold increases in the cell envelope stress response, as 184 
evidenced by the increased expression of the ypuA promoter after a 1 hour incubation. A 185 
significant stress response was still evident after 4 hours exposure to all peptides (Smp24 186 
176% ± 35.6, Smp24T 166 % ± 28.1, Smp24GVG 183% ± 21.9 & Smp43 131 ± 26.2) 187 
(Fig.1). Interestingly, with the exception of Smp43, all peptides induced an up regulation of 188 
the gene associated with DNA synthesis stress; Smp24GVG showed the greatest (288.4% ± 189 
14.2) increase in the expression of the yorB promoter after 3 hours whilst Smp24 and 190 
Smp24T increased expression by 228.1 % (± 12.1) and 163.3% (±6.4) respectively at the 191 
same time point. A comparison of cell envelope and DNA stress responses would suggest 192 
that the cell envelope has entered a recovery phase when the peptide is exerting maximum 193 
damage (either directly or indirectly) on bacterial DNA synthesis. In contrast to the induction 194 
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of DNA stress responses, the genes associated with RNA or protein synthesis related stress 195 
responses were not significantly induced by any of the peptides (Fig. 1). 196 
In haemolysis assays Smp43 showed very low toxicity at the maximum concentration tested 197 
(1.2 ± 0.5 % lysis at 512 μg/ml), in comparison, Smp24 caused significant erythrocyte 198 
disruption (89.6 ±5.6 %) at the same concentration (Fig.2). The effects of modifications to 199 
Smp24 had contrasting outcomes (Fig 2).  Truncated Smp24 showed a decrease in activity, 200 
with haemolysis reduced by 43% at the highest concentration compared with the parent 201 
peptide. However, inclusion of the flexible Gly-Val-Gly hinge region had little effect with no 202 
significant difference in haemolytic activity. Further cytotoxic testing was carried out on 203 
HepG2 cells by measuring the release of ATP (Fig 3) with cell damage occurring in a 204 
concentration-dependent fashion in response to all four peptides above a concentration of 205 
32µg/ml. The consequence of Smp24 modification was similar to those observed in 206 
haemolysis assays with a decrease in cytotoxicity observed with the truncated derivative 207 
(11.8 % (±4.0) at 32 µg/ml compared with 15.9 % (±1.9)) whist Smp24GVG showed no 208 
significant difference compared with the parent peptide (Fig 3). However, there was a 209 
remarkable difference in the cytotoxicity of Smp43 when comparing erythrocyte haemolysis 210 
and the release of ATP from HepG2 cells (94.8% (±7.5) at 512 µg/ml), clearly highlighting 211 
differences in eukaryotic cell membrane architecture and the need for a range of diverse 212 
mammalian cell types to be assayed during cytotoxic testing (Fig. 3). 213 
CD spectral analysis for both Smp24 and Smp43 revealed that both peptides are in an 214 
unordered structure in aqueous solution. However, in the presence of 60 % TFE both peptides 215 
adopt significant alpha helical regions characterised by two minima at 208 nm and 222 nm 216 
(Fig.4). Analysis of both peptides (DichroWeb server, Whitmore and Wallace, 2008) 217 
revealed Smp24 to have two regions of approximately 59 % and 22 % helical content whilst 218 
Smp43 showed two regions of approximately 70 % and 25 % helical content. The remaining 219 
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regions of both peptides were assigned as unordered. The percentage helical content was 220 
estimated using the SELCON method of analysis which determines helical content using 221 
statistical algorithms that were created by analysis of 29 reference proteins. This 222 
methodology was validated by analysing 4 unknown proteins where the structure was also 223 
confirmed by X-ray crystallography (Sreerama et al., 1999). 224 
 225 
Discussion  226 
A large number of scorpion AMPs have been characterised. They have a wide range of 227 
biological activities and their characterisation has been facilitated because their small size 228 
(<5kDa). Abdel Rahman et al., (2013) identified four AMPs in the venom of Scorpio maurus 229 
palmatus and this study characterises the biological activity of three of them.   230 
Smp43 shares high homology (75-86%) with opistoporins and pandinin 1 (Pin 1). 231 
Opistoporin 1 & Pin 1 both have been shown to have helix-hinge-helix structures (Moerman 232 
et al., 2002, Corzo et al., 2001). CD spectral analysis of Smp43 suggested the peptide to be 233 
unordered in aqueous solution whilst in the presence of 60 % TFE it adopted a di-helical 234 
structure, linked by a random coil region. Smp43 showed striking similarity to Pin 1 (helical 235 
regions between 3-18 and 26-37 linked by a random coil region) (Nomura et al., 2005). 236 
Smp24 showed a lower identity (54%) with pandinin-2 (Pin 2), although it shares 237 
evolutionarily conserved motifs with the shorter (17-20 residue) chain scorpion AMPs.  The 238 
most notable among these is the LIPS motif which is found within the core of Pin 2 as well as 239 
BmKb1, ctriporin, imcroporin, meucin-18 and mucroporin. CD spectral analysis of Smp24 240 
revealed, like Smp43, an unordered structure in aqueous solution that adopted a di-helical 241 
structure in 60% TFE.  The structure of Smp24 however is in contrast to that of Pin 2 which 242 
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on the basis of NMR analysis, has only a single helical region, extending from the N-243 
terminus to residue 18 (Nomura et al., 2004). 244 
Despite the differences in structure the two peptides share a number of key features including 245 
length (24 residues), homology (13 identical residues) and biological activity (bactericidal & 246 
cytotoxic) which is highly suggestive of Smp24 belonging to the same family of mid-chain 247 
helical scorpion AMPs. The shorter Smp13 belongs to the family of cytotoxic peptides such 248 
as IsCT peptides (Dai et al., 2002). However, unlike other peptides within this family, Smp13 249 
carries no charge and therefore it is not surprising that it has no antimicrobial activity. Its role 250 
within the venom remains to be elucidated. 251 
The helix-hinge-helix topology of Smp43 is present in a number of longer chain AMPs, all of 252 
which have high therapeutic indices, for example cecroprin A (Holak et al., 1988), 253 
dermaseptin B2 (Galanth et al., 2009), Hadrurin (Torres-Larios et al., 2000), the opistoporins 254 
(Moerman et al., 2002), Pin1 (Corzo et al., 2001) and BmKbpp (Zeng et al., 2000).  This 255 
suggests that this class of peptides has considerable potential for the future development of 256 
anti-infective agents.  257 
Suggestions that substitution of a proline residue with a more flexible Gly-Val-Gly (GVG) 258 
"hinge" would reduce the haemolytic effects of AMPs has been proposed by Rodriguez and 259 
colleagues and, in the case of Pin2, has proved successful (Rodriguez et al., 2011). However 260 
there was no difference in the haemolytic activities of Smp24 and Smp24GVG. 261 
 262 
It should be noted that the effect of proline within AMPs is ambiguous. On the one hand, 263 
many proline-deficient peptides (e.g. magainin-2) show low haemolytic/cytotoxic activity 264 
(Zasloff., 1987).    In contrast, peptides such as melittin and pardaxin contain a proline in the 265 
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central region of their sequence and both have high antimicrobial and haemolytic potential.  266 
Removal of this proline residue further increases toxicity (Dempsey et al., 1991).   Bodone et 267 
al. (2013) have suggested that a proline "kink" is required for prokaryotic membrane 268 
selectivity, with removal only increasing toxicity due to increased helical structure.  This turn 269 
increases the hydrophobic face of the peptide and its propensity to bind to neutrally charged 270 
bilayers.  In contrast, more compact proline-containing peptides will be less attracted to 271 
neutral surfaces and retain electrostatic attraction to negatively charged bilayers.  272 
Reducing the length of the C-terminal of Smp24 by the removal of the last four residues 273 
increased the therapeutic index. This modification was chosen as it had been successfully 274 
performed with the evolutionary related Pin 2 where the shortening of the random coil region 275 
increased its therapeutic index despite a reduction in charge (Rodriguez et al., 2014) although 276 
this electrostatic attraction is less important towards eukaryotic membranes due to their 277 
zwitterionic nature (Jiang et al., 2008). The reduction in haemolysis seen in Pin 2 after 278 
truncation to 14 and 17 residue peptides is of interest as CD spectra showed a change in 279 
structure from a predominantly helical structure to a β-hairpin structure similar to Indolicidin 280 
(Rodriquez et al., 2014).  281 
Although Smp43 exhibited low haemolysis it still caused significant ATP release in HepG2 282 
cells suggesting disruption of eukaryotic membranes. However, it is worth noting cancer 283 
derived cells have a more negatively charged membrane than normal eukaryotic cells due to 284 
an increase in membrane phosphatidylserine content, differential branching and sialic acid 285 
content of N-linked glycans associated with transmembrane proteins and the increase in O-286 
glycoslylated mucins (Gajski and Garaj-Vrhovac., 2013). On this basis it would be useful to 287 
assess any toxic effects on primary cells which exhibit normal membrane compositions both 288 
to redefine peptide toxicity and determine any beneficial anticancer properties.    289 
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Along with their membrane disruptive mechanism the stress responses with B. subtilis whole 290 
cell reporter assays showed a possible interaction with DNA for Smp24 and its derivatives. A 291 
number of peptides have been shown to interact with intracellular targets including DNA.  292 
These include buforin II (BFII) as a prototypical example (Yonezawa et al., 1992, Park et al., 293 
1998, Zhang et al., 2014), which also contains a proline in the centre of the peptide (Park et 294 
al., 1998). BFII penetrates the membrane without causing general membrane 295 
permeabilisation and accumulates in the cytosol before binding to DNA. In contrast, proline 296 
deficient magainin 2 (MAG 2), causes membrane permeabilisation but stays bound to the 297 
phospholipid bilayer and has a low propensity for DNA binding (Kobayashi et al., 2004). 298 
Both peptides form transient toroidal pores although BFII pores have a significantly shorter 299 
half-life (Park et al., 2000).  Pore collapse is electrostatically driven by repulsive forces 300 
within the helical portion of the peptide (Kobayashi et al., 2004). Further evidence for the 301 
destabilising effect of proline is found in alamethicin where substitution of alanine for proline 302 
is known to destabilise the pore (Kaduk et al., 1998). Since Smp24 both disrupts membranes 303 
and may have an intracellular target, we propose that the highly charged nature of the peptide 304 
(+4) together with the presence of proline could create a “half-way house” between BFII and 305 
MAG 2. Although Smp24 has a longer pore half-life than BFII, we suggest that, unlike MAG 306 
2, Smp24 can still dissociate from the phospholipid bilayer and interact with DNA.  In this 307 
context however, the observation that Smp24GVG did not diminish the DNA stress response, 308 
needs further investigation.   309 
The fact that the intracellular stress responses of Smp43 were limited to the cell envelope is 310 
perhaps not surprising, when considering that Pin1 causes complete disruption of the bilayer 311 
(Nomura et al., 2005). Biophysical studies in our own laboratory (unpublished observations) 312 
support a carpet-like mechanism for Smp43, similar to Pin 1. 313 
14 
 
Antimicrobial assays of the peptides from S. maurus palmatus studied in our experiments 314 
show wide differences in MIC values, especially between Gram-positive and Gram-negative 315 
bacteria, with preferential activity towards Gram-positive bacteria, in keeping with previously 316 
tested α-helical peptides from scorpion venom (Harrison et al., 2014). This is perhaps not 317 
surprising when considering the failure to produce Gram-negative specific invectives in 318 
recent years and highlights the intrinsic difficulty in identifying suitable Gram-negative 319 
specific agents. 320 
In summary, three scorpion AMPs have been characterised from the venom of S. maurus 321 
palmatus. Two of these peptides (Smp24 & Smp43) showed broad spectrum antimicrobial 322 
activity but differed significantly in their haemolytic effects whilst the shortest peptide 323 
(Smp13) had no biological activity. Different modifications of Smp24 led to both beneficial 324 
and adverse biological effects and highlighted the potential for further manipulation of these 325 
peptides as AMP scaffolds. Both Smp24 and Smp43 exhibited a membrane disruptive 326 
mechanism of action, however Smp24 and its derivatives showed evidence of interference 327 
with DNA synthesis.  In accord with previous studies (Torres-Larios et al., 2000, Moerman et 328 
al., 2002, Corzo et al., 2001 and Zeng et al., 2000), our experiments further highlight the 329 
beneficial effect that a helical-hinge-helical conformation has on long chain scorpion AMPs 330 
in promoting prokaryotic selectivity.  331 
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HepG2 cells measured as a function of ATP release.  482 
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Table 1. 486 
Peptide name Sequence 
Smp13 ILQDIWNGIKNLF-NH2 
Smp24 
Pandinin-2 
Smp24GVG 
Smp24T 
IWSFLIKAATKLLP--SLFGGG-KKDS 
FWGALAKGALKLIP--SLFSSFSKKD 
IWSFLIKAATKLLGVGSLFGGG-KKDS 
IWSFLIKAATKLL--PSLFGG 
Smp43 
Pandinin-1 
G-VWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS 
GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT 
 487 
Table 2. 488 
Bacteria strain Gram 
class 
MIC (µg/ml) 
    Smp 13 Smp 24 Smp 24 
GVG 
Smp 
24T 
Smp 43 
B. subtilis NCIMB 8024 + No Activity 4 8 8 4 
S. epidermidis sp. + No Activity 8 16 16 64 
S. aureus SH100 + No Activity 8 16 16 32 
E. coli JM109 - No Activity 64 64 128 128 
K. pneumoniae NCTC 13439 - No Activity 128 128 128 64 
P. aeruginosa - No Activity 256 256 256 64 
C. albicans fungi No Activity 32 128 128 128 
 489 
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Table 3. 491 
S.aureus strain MIC (µg/ml) 
  
SH1000 32 
S.aureus ATCC 25923 32 
  
MRSA ATCC 33591 512 (Partial) 
MRSA mecA mupA +ve 16 
EMRSA-15 16 
EMRSA-16 512 (Partial) 
  
VISA MU50 32 
VISA KM126 64 
Table 4. 492 
 
% Membrane damage 
Species/Strain  Smp24 Smp24GVG Smp24T Smp43 
E.coli JM109 110.5 (±3.9) 97.2 (±1.2) 99.5 (±3.5) 105.4 (±1.8) 
S.aureus 
SH1000 101.2 (±4.8) 105.3 (±4.5) 11.6 (±2.9) 103.2 (±5.1) 
 493 
25 
 
 
Figure 1. 
26 
 
 
Figure 2. 
 
27 
 
 
Figure 3. 
 
 
 
28 
 
 
 
Figure 4 
 
 
 
